CRT 2026

LATE-BREAKING CLINICAL TRIALS | SATURDAY

Moderator(s)

• 

  Gregg W. Stone, MD, FACC, MSCAI

  Physician
  Mount Sinai
  New York, New York, United States

  Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

Panel Discussant(s)

• 

  David J. Cohen, MD, FSCAI

  Director of Clinical and Outcomes Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
• 

  David L. Fischman, MD

  Director, Intervention Fellowship Program. Co-Director Cardiac Cath Lab
  Thomas Jefferson University Hospital
  Mount Laurel, New Jersey, United States

  Disclosure(s): No financial relationships to disclose
• 

  C. Michael Gibson, MD

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Dean J. Kereiakes, MD, FACC, MSCAI

  Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
  The Christ Hospital Health Network
  Cincinnati, Ohio, United States

  Disclosure information not submitted.
• 

  Neal S. Kleiman, MD, FACC, MSCAI

  Medical Director, Cardiac Catheterization Laboratories
  Houston Methodist DeBakey Heart and Vascular Center
  Houston, Texas, United States

  Disclosure information not submitted.
• 

  Bruno Scheller, MD

  Professor of Clinical and Experimental Interventional Cardiology
  University of Saarland
  Homburg, Saarland, Germany

  Disclosure(s): B.Braun: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InnoRa GmbH: Owner/Co-Owner Founder/Co-Founder (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)